HIM
WST icon

Hanlon Investment Management’s West Pharmaceutical WST Stock Holding History

Hanlon Investment Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,965
Closed -$1.22M – 130
2022
Q1 		$1.22M Sell
2,965
-50
-2% -$19.6K 0.26% 59
2021
Q4 		$1.41M Buy
3,015
+5
+0.2% +$2.15K 0.27% 61
2021
Q3 		$1.28M Buy
+3,010
New +$1.27M 0.26% 61

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Hanlon Investment Management's WST Position: Q2 2022 in Review

Hanlon Investment Management sold out of West Pharmaceutical (WST) in Q2 2022, closing a stake of 2,965 shares — an estimated $1.22M sold.

Hanlon Investment Management first reported a position in WST in Q3 2021 and held it in 3 quarters. The position peaked at $1.41M in Q4 2021. 655 funds tracked by Wall St. Rank hold WST as of Q2 2022.

  • Hanlon Investment Management reported no remaining West Pharmaceutical position as of Q2 2022 after selling out during the quarter.
  • Hanlon Investment Management sold 2,965 West Pharmaceutical shares in Q2 2022, an estimated $1.22M.
  • Hanlon Investment Management first reported a position in West Pharmaceutical in Q3 2021 and held it in 3 quarters.
  • Hanlon Investment Management's West Pharmaceutical position peaked at $1.41M in Q4 2021.
  • 655 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2022.

Based on Hanlon Investment Management's 13F filing for Q2 2022, filed 27 Jul 2022.